Thomas R Garland

Title: Innovations of Thomas R. Garland in Technetium Reduction

Introduction

Thomas R. Garland is an accomplished inventor based in Greybull, Wyoming. He has made significant contributions to the field of microbial methods for reducing technetium compounds, which are valuable in medical imaging. With a total of 2 patents, his work has the potential to enhance the efficiency and effectiveness of technetium-based medical applications.

Latest Patents

Garland's latest patents include innovative methods and kits for microbial reduction of technetium compounds. The first patent, titled "Microbial methods of reducing technetium," focuses on a method that combines technetium compounds with non-growing microbial cells containing a technetium-reducing enzyme system. This process occurs in a saline solution under anaerobic conditions, resulting in technetium of lower oxidation states. The microorganisms, specifically strain Bry and strain CN-32, have been identified as capable of facilitating this reduction.

The second patent, "Kit for providing a technetium medical radioimaging agent," outlines a similar approach. It describes a kit that combines technetium compounds with microbial cells and stabilizing agents to produce valuable compounds for medical imaging. The resulting technetium can be partially controlled by the stabilizing agent, further enhancing its utility in medical applications.

Career Highlights

Garland is associated with the Battelle Memorial Institute, where he has been able to apply his expertise in microbial reduction techniques. His work has contributed to advancements in medical imaging technologies, showcasing his commitment to innovation in the field.

Collaborations

Throughout his career, Garland has collaborated with notable colleagues, including Raymond E. Wildung and Shu-Mei W. Li. These partnerships have likely enriched his research and contributed to the successful development of his patented technologies.

Conclusion

Thomas R. Garland's innovative work in microbial methods for technetium reduction represents a significant advancement in medical imaging technology. His contributions have the potential to improve the efficiency of technetium-based applications, making a lasting impact in the field.